These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33478397)

  • 1. High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial.
    Jarusriwanna A; Phusunti S; Chotiyarnwong P; Unnanuntana A
    BMC Geriatr; 2021 Jan; 21(1):72. PubMed ID: 33478397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation.
    Papaioannou A; Kennedy CC; Giangregorio L; Ioannidis G; Pritchard J; Hanley DA; Farrauto L; DeBeer J; Adachi JD
    BMC Musculoskelet Disord; 2011 Jun; 12():135. PubMed ID: 21689448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome.
    Sansanayudh N; Wongwiwatthananukit S; Phetkrajaysang N; Krittiyanunt S
    Int J Clin Pharm; 2014 Aug; 36(4):771-8. PubMed ID: 24853094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
    Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
    Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Hypovitaminosis D in Patient with Fragility Hip Fracture at a Single Institution in Thailand.
    Phusunti S; Suthutvoravut W; Unnanuntana A; Chotiyarnwong P
    J Med Assoc Thai; 2016 Nov; 99(11):1233-8. PubMed ID: 29901944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
    Glendenning P; Chew GT; Seymour HM; Gillett MJ; Goldswain PR; Inderjeeth CA; Vasikaran SD; Taranto M; Musk AA; Fraser WD
    Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women.
    Mueangpaisarn P; Chaiamnuay S
    Aging Clin Exp Res; 2020 Jan; 32(1):41-48. PubMed ID: 30784012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
    Melhem SJ; Aiedeh KM; Hadidi KA
    Ann Saudi Med; 2015; 35(1):13-8. PubMed ID: 26142932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An initial loading-dose vitamin D versus placebo after hip fracture surgery: baseline characteristics of a randomized controlled trial (REVITAHIP).
    Mak JC; Klein LA; Finnegan T; Mason RS; Cameron ID
    BMC Geriatr; 2014 Sep; 14():101. PubMed ID: 25200552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of vitamin D in hospital-based fracture care pathways.
    Glowacki J; LeBoff MS; Kolatkar NS; Thornhill TS; Harris MB
    J Nutr Health Aging; 2008 May; 12(5):291-3. PubMed ID: 18443709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional vitamin D supplementation in dialysis: a randomized trial.
    Bhan I; Dobens D; Tamez H; Deferio JJ; Li YC; Warren HS; Ankers E; Wenger J; Tucker JK; Trottier C; Pathan F; Kalim S; Nigwekar SU; Thadhani R
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):611-9. PubMed ID: 25770176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitamin D deficiency within a large integrated health care delivery system.
    Stratton-Loeffler MJ; Lo JC; Hui RL; Coates A; Minkoff JR; Budayr A
    J Manag Care Pharm; 2012 Sep; 18(7):497-505. PubMed ID: 22971203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of vitamin D2 supplementation on muscle strength in early postmenopausal women: a randomized, double-blind, placebo-controlled trial.
    Suebthawinkul C; Panyakhamlerd K; Yotnuengnit P; Suwan A; Chaiyasit N; Taechakraichana N
    Climacteric; 2018 Oct; 21(5):491-497. PubMed ID: 30095022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.
    Bischoff-Ferrari HA; Willett WC; Wong JB; Giovannucci E; Dietrich T; Dawson-Hughes B
    JAMA; 2005 May; 293(18):2257-64. PubMed ID: 15886381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An initial loading-dose vitamin D versus placebo after hip fracture surgery: randomized trial.
    Mak JC; Mason RS; Klein L; Cameron ID
    BMC Musculoskelet Disord; 2016 Aug; 17():336. PubMed ID: 27515154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.
    Dickerson RN; Berry SC; Ziebarth JD; Swanson JM; Maish GO; Minard G; Brown RO
    Nutrition; 2015 Oct; 31(10):1219-23. PubMed ID: 26213135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Resident-led Initiative Improves Screening and Treatment for Vitamin D Deficiency in Patients with Hip Fractures.
    Lansdown DA; Whitaker A; Wustrack R; Sawyer A; Hansen EN
    Clin Orthop Relat Res; 2017 Jan; 475(1):264-270. PubMed ID: 27549989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial.
    Hammami MM; Abuhdeeb K; Hammami S; Yusuf A
    BMC Endocr Disord; 2019 Jan; 19(1):8. PubMed ID: 30658603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.